Joshua T. Kowalczyk

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma”.

Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-20-0525

N/A

0DataRank · unranked

20 citations

Xiaolin Wan, Edjay R. Hernandez, Ruibai Luo, Gaelyn C. Lyons, Kelli M. Wilson +17 more

Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation

Cells(2022)10.3390/cells11233826

N/A

0DataRank · unranked

31 citations

Joshua T. Kowalczyk, Sandy Reynolds, James W. Hodge, Kellsye P. Fabian

Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies

Frontiers in Oncology(2022)10.3389/fonc.2022.1012058

N/A

0DataRank · unranked

28 citations

Yvette Robbins, Joshua T. Kowalczyk, Wiem Lassoued, James L. Gulley, Markku Miettinen +5 more

Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005752

N/A

0DataRank · unranked

9 citations

Kellsye P. Fabian, Michelle R. Padget, Diana C. Lopez, Austin T.K. Hoke, Clint Allen +4 more

KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma.

Research Square(2022)10.21203/rs.3.rs-2298627/v1

N/A

0DataRank · unranked

0 citations

Berkley E. Gryder, Ranuka Sinniah, Megan L. Peach, Jack F. Shern, Abdalla Abdelmaksoud +26 more

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03459-7

N/A

0DataRank · unranked

7 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Kristen Solocinski, Paul L. Chariou, Duane H. Hamilton +6 more

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma

Nature Communications(2024)10.1038/s41467-024-45902-y

N/A

0DataRank · unranked

18 citations

Berkley E. Gryder, Ranuka Sinniah, Megan L. Peach, Jack F. Shern, Abdalla Abdelmaksoud +27 more

Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma

Cancers(2024)10.3390/cancers16132320

N/A

0DataRank · unranked

6 citations

Jacob S. Roth, Edjay R. Hernandez, Joshua T. Kowalczyk, Nancy E. Sealover, Katie E. Hebron +17 more

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

Frontiers in Oncology(2024)10.3389/fonc.2024.1376622

N/A

0DataRank · unranked

3 citations

Kellsye P. Fabian, Michelle R. Padget, Yvette Robbins, Joshua T. Kowalczyk, Wiem Lassoued +7 more